InterPro

From WikiMD's WELLNESSPEDIA

InterPro is a database that integrates together predictive information about proteins' function from several different resources. The information is derived from diagnostic models, known as "signatures", provided by each member database of InterPro consortium that are used to build an InterPro entry, a curated protein signature database of the consortium.

Overview[edit]

InterPro is a consortium that combines the efforts of the Protein Information Resource (PIR), PROSITE, PRINTS, ProDom, Pfam, SMART, TIGRFAMs, PIRSF, SUPERFAMILY, Gene3D and PANTHER. The consortium was established in 1999, initially funded by the European Bioinformatics Institute (EBI) and later by the National Institutes of Health (NIH).

InterPro's goal is to provide an integrated documentation resource for protein families, domains and functional sites, to aid in the functional characterization of new sequences. It does this by amalgamating the predictive signatures into one resource, capitalizing on their individual strengths to produce a powerful integrated database and diagnostic tool.

Function[edit]

InterPro uses predictive models, known as signatures, provided by several different databases, to predict the function of uncharacterized protein sequences. These signatures are then used to build an InterPro entry. Each entry includes a concise description of the group of proteins it covers, including details of any associated protein domains, repeats and important sites, along with an extensive bibliography.

See also[edit]

References[edit]


External links[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.